223 related articles for article (PubMed ID: 9353017)
1. Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose.
Estabrook MM; Griffiss JM; Jarvis GA
Infect Immun; 1997 Nov; 65(11):4436-44. PubMed ID: 9353017
[TBL] [Abstract][Full Text] [Related]
2. Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophils.
Estabrook MM; Zhou D; Apicella MA
Infect Immun; 1998 Mar; 66(3):1028-36. PubMed ID: 9488392
[TBL] [Abstract][Full Text] [Related]
3. α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.
Lewis LA; Gulati S; Burrowes E; Zheng B; Ram S; Rice PA
mBio; 2015 Feb; 6(1):. PubMed ID: 25650401
[TBL] [Abstract][Full Text] [Related]
4. A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.
Ram S; Gulati S; Lewis LA; Chakraborti S; Zheng B; DeOliveira RB; Reed GW; Cox AD; Li J; St Michael F; Stupak J; Su XH; Saha S; Landig CS; Varki A; Rice PA
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844237
[TBL] [Abstract][Full Text] [Related]
5. Molecular mimicry of host structures by lipooligosaccharides of Neisseria meningitidis: characterization of sialylated and nonsialylated lacto-N-neotetraose (Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc) structures in lipooligosaccharides using monoclonal antibodies and specific lectins.
Tsai CM
Adv Exp Med Biol; 2001; 491():525-42. PubMed ID: 14533820
[TBL] [Abstract][Full Text] [Related]
6. Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci.
Gulati S; Cox A; Lewis LA; Michael FS; Li J; Boden R; Ram S; Rice PA
Infect Immun; 2005 Nov; 73(11):7390-7. PubMed ID: 16239538
[TBL] [Abstract][Full Text] [Related]
7. Factor H binding and function in sialylated pathogenic neisseriae is influenced by gonococcal, but not meningococcal, porin.
Madico G; Ngampasutadol J; Gulati S; Vogel U; Rice PA; Ram S
J Immunol; 2007 Apr; 178(7):4489-97. PubMed ID: 17372007
[TBL] [Abstract][Full Text] [Related]
8. The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.
Kahler CM; Martin LE; Shih GC; Rahman MM; Carlson RW; Stephens DS
Infect Immun; 1998 Dec; 66(12):5939-47. PubMed ID: 9826376
[TBL] [Abstract][Full Text] [Related]
9.
Cardenas AJ; Thomas KS; Broden MW; Ferraro NJ; Pires MM; John CM; Jarvis GA; Criss AK
mBio; 2024 May; 15(5):e0011924. PubMed ID: 38587424
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of N-acetylneuraminic acid into Haemophilus somnus lipooligosaccharide (LOS): enhancement of resistance to serum and reduction of LOS antibody binding.
Inzana TJ; Glindemann G; Cox AD; Wakarchuk W; Howard MD
Infect Immun; 2002 Sep; 70(9):4870-9. PubMed ID: 12183531
[TBL] [Abstract][Full Text] [Related]
11. Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.
Schmiel DH; Moran EE; Keiser PB; Brandt BL; Zollinger WD
Infect Immun; 2011 Oct; 79(10):4146-56. PubMed ID: 21768280
[TBL] [Abstract][Full Text] [Related]
12. Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis.
Kim JJ; Zhou D; Mandrell RE; Griffiss JM
Infect Immun; 1992 Oct; 60(10):4439-42. PubMed ID: 1398958
[TBL] [Abstract][Full Text] [Related]
13. Bypassing Phase Variation of Lipooligosaccharide (LOS): Using Heptose 1 Glycan Mutants To Establish Widespread Efficacy of Gonococcal Anti-LOS Monoclonal Antibody 2C7.
Chakraborti S; Gulati S; Zheng B; Beurskens FJ; Schuurman J; Rice PA; Ram S
Infect Immun; 2020 Jan; 88(2):. PubMed ID: 31818965
[TBL] [Abstract][Full Text] [Related]
14. Decoration of Histophilus somni lipooligosaccharide with N-acetyl-5-neuraminic acid enhances bacterial binding of complement factor H and resistance to killing by serum and polymorphonuclear leukocytes.
Inzana TJ; Balyan R; Howard MD
Vet Microbiol; 2012 Dec; 161(1-2):113-21. PubMed ID: 22868182
[TBL] [Abstract][Full Text] [Related]
15. Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis.
Vogel U; Weinberger A; Frank R; Müller A; Köhl J; Atkinson JP; Frosch M
Infect Immun; 1997 Oct; 65(10):4022-9. PubMed ID: 9317002
[TBL] [Abstract][Full Text] [Related]
16. Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics.
Gulati S; Schoenhofen IC; Whitfield DM; Cox AD; Li J; St Michael F; Vinogradov EV; Stupak J; Zheng B; Ohnishi M; Unemo M; Lewis LA; Taylor RE; Landig CS; Diaz S; Reed GW; Varki A; Rice PA; Ram S
PLoS Pathog; 2015 Dec; 11(12):e1005290. PubMed ID: 26630657
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of an isogenic meningococcal alpha-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci.
Vogel U; Claus H; Heinze G; Frosch M
Med Microbiol Immunol; 1997 Oct; 186(2-3):159-66. PubMed ID: 9403845
[TBL] [Abstract][Full Text] [Related]
18. Influence of the length of the lipooligosaccharide alpha chain on its sialylation in Neisseria meningitidis.
Tsai CM; Kao G; Zhu P
Infect Immun; 2002 Jan; 70(1):407-11. PubMed ID: 11748209
[TBL] [Abstract][Full Text] [Related]
19. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.
Jarvis GA; Vedros NA
Infect Immun; 1987 Jan; 55(1):174-80. PubMed ID: 3098684
[TBL] [Abstract][Full Text] [Related]
20. Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates.
Vogel U; Claus H; Heinze G; Frosch M
Infect Immun; 1999 Feb; 67(2):954-7. PubMed ID: 9916114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
